These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2284952)
21. Fibrin-stabilizing factor inhibitors. I. Amides and esters of trans-4-(aminomethyl)cyclohexane carboxylic acid (tranexamic acid). Nilsson JL; Stenberg P; Eriksson O; Lundén R Acta Pharm Suec; 1970 Sep; 7(4):441-8. PubMed ID: 5480084 [No Abstract] [Full Text] [Related]
22. A bifunctional monocyclic beta-lactam cross-links across the active site of beta-lactamase. Ahluwalia R; Day RA; Nauss J Biochem Biophys Res Commun; 1995 Jan; 206(2):577-83. PubMed ID: 7826374 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of some new benzimidazole derivatives as potential antimicrobial agents. Ansari KF; Lal C Eur J Med Chem; 2009 May; 44(5):2294-9. PubMed ID: 18316140 [TBL] [Abstract][Full Text] [Related]
26. Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence. Totir MA; Cha J; Ishiwata A; Wang B; Sheri A; Anderson VE; Buynak J; Mobashery S; Carey PR Biochemistry; 2008 Apr; 47(13):4094-101. PubMed ID: 18324783 [TBL] [Abstract][Full Text] [Related]
27. [Determination of the beta-lactamase-inhibiting capacity of different compounds by using a penicillinase-forming strain of Staphylococcus aureus 5A]. Nikishina VG; Ivanitskaia LP; Bibikova MV Antibiotiki; 1981 Oct; 26(10):735-40. PubMed ID: 6975597 [TBL] [Abstract][Full Text] [Related]
28. Synthesis of 3-Substituted-clavams: Antifungal Properties, DD-Peptidase and beta-Lactamase Inhibition. Cierpucha M; Panfil I; Danh TT; Chmielewski M; Kurzatkowski W; Rajnisz A; Solecka J J Antibiot (Tokyo); 2007 Oct; 60(10):622-32. PubMed ID: 17965478 [TBL] [Abstract][Full Text] [Related]
29. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters. Takai S; Jin D; Sakaguchi M; Katayama S; Muramatsu M; Sakaguchi M; Matsumura E; Kim S; Miyazaki M J Pharmacol Exp Ther; 2003 Apr; 305(1):17-23. PubMed ID: 12649348 [TBL] [Abstract][Full Text] [Related]
30. Bacteriological investigations with beta-lactamase inhibitors. Ullmann U Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565 [TBL] [Abstract][Full Text] [Related]
31. [Beta-lactamase inhibitors. II. Synthesis and biological properties of 6-sulfonylaminopenicillanic acids]. Kazimierczak J; Mikołajczyk J; Kotulowa W; Cieślak J Acta Pol Pharm; 1984; 41(6):619-23. PubMed ID: 6100225 [No Abstract] [Full Text] [Related]
32. Syntheses and complement inhibitory activities of 4-(2-phenyl-1H-indol-3-yl)cyclohexane-1-carboxylic acids. Bailey DM; DeGrazia GD; Alexander EJ; Powles RG; Johnson RE; Patrick RA; Heerdt BG; Fairbain ME; Pruden DJ J Med Chem; 1985 Feb; 28(2):160-4. PubMed ID: 3155799 [TBL] [Abstract][Full Text] [Related]
33. [Synthesis of some derivatives of 2-methyl-4-(2',2',6'-trimethyl-cyclohexyl)-butane-1-carboxylic acid]. Zawisza T Acta Pol Pharm; 1975; 32(1):15-24. PubMed ID: 1114908 [No Abstract] [Full Text] [Related]
34. [Inhibitory effect of 4-(2-carboxyethyl) phenyl trans-4-aminomethyl cyclohexane carboxylate hydrochloride on fibrinolysis, esterolysis and proteolysis and its degradation by serum esterases: in vitro study]. Nagamatsu Y; Matsumoto M; Yamamoto J; Okamoto U Nihon Ketsueki Gakkai Zasshi; 1973 Apr; 36(2):150-8. PubMed ID: 4738466 [No Abstract] [Full Text] [Related]
37. [The synthesis of 4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexane carboxylate hydrochloride (cetraxate hydrochloride) by means of enzymatic debenzylation]. Kuroda H; Miyadera A; Kaneuchi T; Imura A Yakugaku Zasshi; 1989 Mar; 109(3):157-62. PubMed ID: 2754616 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of a broad array of highly functionalized, enantiomerically pure cyclohexanecarboxylic acid derivatives by microbial dihydroxylation of benzoic acid and subsequent oxidative and rearrangement reactions. Myers AG; Siegel DR; Buzard DJ; Charest MG Org Lett; 2001 Sep; 3(18):2923-6. PubMed ID: 11529791 [TBL] [Abstract][Full Text] [Related]
39. beta-Lactamase inhibitors derived from N-tosyloxy-beta-lactams. Teng M; Miller MJ; Nicas TI; Grissom-Arnold J; Cooper RD Bioorg Med Chem; 1993 Aug; 1(2):151-4. PubMed ID: 8081845 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of the optical isomers of 4-[1-(4-tert-butylphenyl)-2-oxo- pyrrolidine-4-yl]methyloxybenzoic acid (S-2) and their biological evaluation as antilipidemic agent. Ohno T; Yano S; Yamada H; Shirasaka T; Yamamoto A; Kobayashi K; Ogawa K Chem Pharm Bull (Tokyo); 1999 Nov; 47(11):1549-54. PubMed ID: 10605053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]